United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - betaine - oral solution - 500mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - betaine - oral tablet - 500mg

Israel - English - Ministry of Health

medison pharma ltd - betaine anhydrous - powder for solution - betaine anhydrous 1 g/g - betaine - treatment of homocystinuria.

Australia - English - Department of Health (Therapeutic Goods Administration)

neolife international pty ltd - betaine hydrochloride, quantity: 275 mg; pepsin, quantity: 130 mg; papain, quantity: 10 mg; beta vulgaris, quantity: 5 mg; rhubarb, quantity: 5 mg; pectin, quantity: 3 mg; liquorice, quantity: 2 mg - tablet, film coated - excipient ingredients: cellulose; colloidal anhydrous silica; magnesium stearate; calcium hydrogen phosphate dihydrate; guar gum; carob gum - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

marlborough pharmaceuticals ltd - cloral betaine - oral tablet - 707mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - cloral betaine - oral tablet - 707mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - cloral betaine - oral tablet - 707mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - cloral betaine - oral tablet - 707mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - cloral betaine - oral tablet - 707mg

European Union - English - EMA (European Medicines Agency)

recordati rare diseases - betaine anhydrous - homocystinuria - other alimentary tract and metabolism products, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl).cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.